Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001104659-14-071521
Filing Date
2014-10-14
Accepted
2014-10-14 13:03:22
Documents
1
Period of Report
2014-10-09

Document Format Files

Seq Description Document Type Size
1 4/A a4a.html 4/A  
1 4/A a4a.xml 4/A 3737
  Complete submission text file 0001104659-14-071521.txt   5142
Mailing Address 11119 NORTH TORREY PINES ROAD SUITE 200 LA JOLLA CA 92037
Business Address 11119 NORTH TORREY PINES ROAD SUITE 200 LA JOLLA CA 92037 858-550-7500
LIGAND PHARMACEUTICALS INC (Issuer) CIK: 0000886163 (see all company filings)

EIN.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address DORSET MANAGEMENT CORP 485 UNDERHILL BLVD SUITE 205 SYOSSET NY 11791
Business Address
Sabba Stephen L (Reporting) CIK: 0001442372 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-33093 | Film No.: 141154575